Multiple acyl-coa dehydrogenase deficiency is a rare inherited disorder that affects how the body turns fats and some proteins into energy. It is often recognized in newborns or infancy, but some people with Multiple acyl-coa dehydrogenase deficiency are diagnosed later in childhood or adulthood. Signs can include low blood sugar, poor feeding, vomiting, muscle weakness, low muscle tone, and liver or heart problems, while early symptoms of Multiple acyl-coa dehydrogenase deficiency in later-onset cases may look more like tiredness, exercise intolerance, or repeated episodes of muscle pain.
Not everyone will have the same experience. Multiple acyl-coa dehydrogenase deficiency is usually lifelong, and the outlook depends on how severe it is, with the most severe forms carrying a risk of serious illness or death in early life. Treatment often includes avoiding fasting, using a low-fat and carefully planned diet, and taking supplements such as riboflavin and sometimes carnitine under specialist care.
How many people live with Multiple acyl-coa dehydrogenase deficiency?
Multiple acyl-CoA dehydrogenase deficiency is extremely rare, and Orphanet lists it as affecting fewer than 1 in 1,000,000 people, which suggests fewer than about 8,200 people worldwide (Orphanet, 2024). Using that same prevalence and current U.S. population size, this would mean fewer than about 340 people in the United States, although that is an estimate rather than a direct national count (Orphanet, 2024; U.S. Census Bureau, 2024).
Overview
Multiple acyl-coa dehydrogenase deficiencySymptoms
Multiple acyl-CoA dehydrogenase deficiency can cause low energy, weak muscles, poor feeding, and vomiting. Some babies have low blood sugar or breathing trouble. Features vary widely, from severe illness in newborns to milder later-onset muscle weakness.
Outlook and prognosis
The outlook for multiple acyl-coa dehydrogenase deficiency varies widely. Many people do well with early diagnosis, regular treatment, and avoiding fasting, especially in milder forms. Severe newborn-onset disease can be life-threatening and needs urgent, ongoing specialist care.
Causes and risk factors
Multiple acyl-CoA dehydrogenase deficiency is usually caused by changes in ETFA, ETFB, or ETFDH genes, inherited from both parents. Risk is highest with a family history or related parents; illness, fasting, or heavy exercise can worsen symptoms.
Genetic influences
Genetics are central to Multiple acyl-coa dehydrogenase deficiency, because it is caused by inherited changes in genes involved in energy metabolism. These genetic variations largely determine whether the condition develops and can also influence how severe it is.
Diagnosis
Diagnosis of Multiple acyl-coa dehydrogenase deficiency usually starts with symptoms, exam findings, and abnormal blood or urine tests. Doctors often confirm it with genetic tests. In some cases, muscle biopsy or imaging findings also help.
Treatment and drugs
Treatment for multiple acyl-CoA dehydrogenase deficiency often includes riboflavin, carnitine, and careful meal timing to avoid fasting. Many living with multiple acyl-CoA dehydrogenase deficiency also need a low-fat, higher-carbohydrate diet. During illness, emergency glucose support may be needed.
Symptoms
Going too long without food, having an infection, or doing hard exercise can make people with Multiple acyl-coa dehydrogenase deficiency suddenly weak or very unwell. This inherited condition affects how the body makes energy from fats and some proteins, so the early features of Multiple acyl-coa dehydrogenase deficiency can range from poor feeding and sleepiness in newborns to later episodes of muscle weakness, vomiting, or low blood sugar. Features vary from person to person and can change over time.
Babies may feed slowly, tire during feeds, or vomit after eating. In infants, this can lead to slow growth and dehydration.
Newborns, children, or adults may seem unusually sleepy or hard to wake during an episode. If the energy shortage becomes severe, alertness can drop quickly and may progress to coma.
Blood sugar can fall during fasting, illness, or repeated vomiting. This may cause shakiness, sweating, irritability, seizures, or sudden collapse.
Many living with Multiple acyl-coa dehydrogenase deficiency have weak muscles or low muscle tone, either from infancy or later on. Everyday activities such as climbing stairs, lifting bags, or keeping up with play can take much more effort.
How people usually first notice Multiple acyl-coa dehydrogenase deficiency?
The first signs of multiple acyl-CoA dehydrogenase deficiency are often noticed very early, sometimes in the newborn period, when a baby has trouble feeding, seems unusually sleepy or floppy, vomits, breathes poorly, or develops low blood sugar. In more severe forms, doctors may also notice liver or heart problems, or uncommon physical findings at birth, which can prompt urgent testing. In milder forms, how multiple acyl-CoA dehydrogenase deficiency is first noticed may be later in infancy, childhood, or even adulthood, when episodes of muscle weakness, fatigue, or illness after fasting or infections keep happening and do not have an obvious explanation.
Types of Multiple acyl-coa dehydrogenase deficiency
Multiple acyl-coa dehydrogenase deficiency has a few well-recognized clinical variants, and they mainly differ by when symptoms start and how severe they are. In this inherited condition, changes in certain genes affect how the body turns fats and some proteins into energy, so the variants of Multiple acyl-coa dehydrogenase deficiency can look quite different from one family to another. Symptoms don’t always look the same for everyone. Some forms begin in the newborn period and are very serious, while another often starts later and may be milder or improve with treatment.
Neonatal with anomalies
This is the most severe form and starts at or soon after birth. Babies often have major problems with feeding, breathing, low blood sugar, and low muscle tone, along with birth differences such as unusual facial features or organ changes. This type of Multiple acyl-coa dehydrogenase deficiency can become life-threatening very quickly.
Neonatal without anomalies
This form also begins in the first days of life and is usually very serious, but it does not include the same pattern of obvious birth defects. Newborns may have low blood sugar, acid buildup in the blood, weakness, liver problems, or trouble breathing. Even without visible anomalies, this variant can cause a rapid medical crisis.
Late-onset form
This type can appear from infancy through adulthood and is often the mildest of the types of Multiple acyl-coa dehydrogenase deficiency. Many living with this form have muscle weakness, poor stamina, muscle pain, or episodes of vomiting and low energy, especially during illness, fasting, or heavy exercise. Some people improve clearly with riboflavin treatment, so symptoms may be more manageable than in the newborn forms.
Can I slow down the onset of symptoms?
Only partly: because multiple acyl-CoA dehydrogenase deficiency is an inherited problem with how the body turns food into energy, there is no proven way to prevent it from starting, but careful management may help delay or reduce symptoms in some people. The best-supported steps are avoiding long gaps without food, staying well nourished, getting prompt care during illnesses like fever, vomiting, or infections, and avoiding extreme physical strain, since these can trigger symptoms or sudden worsening. If someone is diagnosed, a metabolic specialist may recommend early monitoring and, for some types, treatment such as riboflavin that can help, but these steps lower risk rather than guarantee prevention.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in multiple acyl-CoA dehydrogenase deficiency, but it usually cannot predict the exact day-to-day picture for one person. Changes in certain genes linked to this condition, especially ETFA, ETFB, or ETFDH, can influence whether symptoms start in a newborn or later in childhood or adulthood, and they may affect severity, from serious problems with breathing, feeding, and low blood sugar early in life to later muscle weakness, exercise intolerance, or repeated episodes of illness. Even so, people with the same gene change can still have different symptoms, so genetics is only one part of the picture.
Causes and risk factors
The main genetic causes of multiple acyl-CoA dehydrogenase deficiency are inherited changes in the ETFA, ETFB, or ETFDH genes. A family history of the condition or parents who both carry the same change raises the chance of a baby being born with it. On top of genetics, everyday habits also matter. Fasting, missed meals, infections, vomiting, and very hard exercise can trigger symptoms in people with multiple acyl-CoA dehydrogenase deficiency. These factors do not cause the condition, but they can make it show up earlier or become more severe.
What are the most common causes or risk factors?
Multiple acyl-CoA dehydrogenase deficiency is usually caused by inherited changes in genes that help the body turn fats and some proteins into energy, so the body cannot use these fuels normally. The main risk factors are having a family history of the condition, having two parents who each carry one changed gene without knowing it, and parents who are related by blood, such as cousins, which raises the chance of inheriting the same changed gene from both sides. There are no well-known lifestyle causes, so it is not usually linked to diet, exercise, or everyday habits.
Environmental and biological risk factors
For multiple acyl-CoA dehydrogenase deficiency, there are very few proven non-genetic risk factors. Doctors often group risks into internal (biological) and external (environmental). For this condition, most outside exposures and routine pregnancy factors have not been shown to be clear causes of the main form, which is why the known risk factors for multiple acyl-CoA dehydrogenase deficiency are limited.
Unlike some congenital conditions, radiation, air pollution, heavy metals, or common chemical exposures have not been proven to cause primary multiple acyl-CoA dehydrogenase deficiency. Research in this area is limited, so doctors do not currently treat these as established risk factors.
Usual maternal illnesses during pregnancy have not been shown to be reliable causes of primary multiple acyl-CoA dehydrogenase deficiency. When doctors review pregnancy history, it is mainly to look for other explanations or reasons symptoms may be noticed earlier.
Prematurity, birth stress, or delivery complications do not appear to create the condition itself. They can affect how soon a baby becomes unwell and when testing is done, rather than changing the chance of having the condition.
Genetic risk factors
When the body has trouble turning fats and some proteins into energy, multiple acyl-CoA dehydrogenase deficiency is usually linked to inherited changes in a small group of genes. Most cases come from changes in ETFA, ETFB, or ETFDH, which help move energy through cells. Some risk factors are inherited through our genes. The exact gene and variant matter, and the genetic causes of multiple acyl-CoA dehydrogenase deficiency can lead to either severe illness in newborns or milder forms that appear later.
ETFA changes: Changes in ETFA can stop one of the cell's energy-transfer helpers from working properly. If both copies of ETFA are affected, this can cause multiple acyl-CoA dehydrogenase deficiency.
ETFB changes: Changes in ETFB affect the same energy pathway and can also cause multiple acyl-CoA dehydrogenase deficiency. Disease usually develops only when both copies of the gene are not working normally.
ETFDH changes: ETFDH is another major gene linked to multiple acyl-CoA dehydrogenase deficiency, especially in later-onset forms. Some people with ETFDH changes still make a small amount of working protein, which can lead to a milder range of disease.
Recessive pattern: Multiple acyl-CoA dehydrogenase deficiency is usually inherited in an autosomal recessive pattern. This means a child must inherit one nonworking copy of the same gene from each parent to have the condition.
Carrier parents: Parents who carry one changed copy are often healthy and may not know it runs in the family. When both parents are carriers of the same MADD-related gene, each pregnancy has a 1 in 4, or 25%, chance of an affected child.
Family history: Having a brother, sister, or close relative with multiple acyl-CoA dehydrogenase deficiency raises the chance that the same gene change is present in the family. If one child is affected, future children may also be at risk because the same two parental gene changes can be passed on again.
Related parents: When parents are biologically related, such as cousins, they are more likely to carry the same rare gene change. This increases the chance of recessive conditions like multiple acyl-CoA dehydrogenase deficiency in their children.
Variant type: The exact gene change can affect how much enzyme activity remains. This helps explain why some people with multiple acyl-CoA dehydrogenase deficiency become sick in the newborn period while others are diagnosed later in life.
Lifestyle risk factors
Multiple acyl-coa dehydrogenase deficiency is usually inherited, so lifestyle habits do not cause it, but daily habits can strongly affect metabolic stability, symptom control, and complication risk. In practice, how lifestyle affects Multiple acyl-coa dehydrogenase deficiency often centers on avoiding catabolic stress, supporting energy balance, and reducing triggers for metabolic decompensation. Diet, activity, illness management, sleep, and substance use can all influence fatigue, muscle symptoms, hypoglycemia risk, and episodes of rhabdomyolysis or organ stress.
Long gaps without food can push the body to rely on fat oxidation, which is impaired in this condition. That can increase the risk of hypoglycemia, lethargy, weakness, or metabolic crisis. Regular meals and planned sick-day nutrition are often central lifestyle risk factors for Multiple acyl-coa dehydrogenase deficiency.
Poor caloric intake or diets that are overly high in fat can worsen energy problems because fat breakdown is limited. Individualized eating plans, sometimes including controlled fat intake and enough carbohydrate and protein, may help reduce metabolic stress. Dietary changes should be guided by a metabolic specialist because needs vary by subtype and severity.
Strenuous or prolonged exercise can trigger muscle pain, weakness, rhabdomyolysis, or marked fatigue when energy demand exceeds what metabolism can supply. Gentle to moderate, paced activity may be better tolerated in some people if nutrition and hydration are adequate. Exercise plans usually need adjustment around symptoms, prior episodes, and specialist advice.
Viral infections, vomiting, fever, or poor intake during illness can quickly increase catabolism and raise the chance of decompensation. Delayed sick-day management is therefore a major practical risk in this condition. Early carbohydrate intake, hydration, and urgent medical review when symptoms escalate can be crucial.
Risk prevention
For people living with Multiple acyl-coa dehydrogenase deficiency, true prevention of the condition itself is usually not possible because it is a genetic disorder present from birth. Prevention instead focuses on avoiding metabolic stress, lowering the chance of sudden illness, and protecting organs and muscles over time. Many with Multiple acyl-coa dehydrogenase deficiency do best when food intake, illness planning, and follow-up care are kept steady rather than left to chance. Prevention is flexible—it adapts to your life and health background.
Going too long without food can trigger a metabolic crisis in Multiple acyl-coa dehydrogenase deficiency because the body may struggle to use stored fat for energy. Regular meals, snacks, and sometimes an overnight feeding plan can help keep energy levels stable.
Fasting is one of the most important triggers to avoid in Multiple acyl-coa dehydrogenase deficiency. Even a short period without eating during sleep, travel, or a stomach bug may need a plan from your medical team.
Fever, vomiting, or diarrhea can quickly raise risk because the body needs more energy during illness. A written sick-day plan often includes extra carbohydrates, early fluids, and clear instructions on when to seek urgent care.
Infections can push the body into metabolic stress before early symptoms of Multiple acyl-coa dehydrogenase deficiency become severe. Vaccines, hand hygiene, and prompt treatment of fever or poor intake can lower that risk.
Can you prevent Multiple acyl-coa dehydrogenase deficiency?
Usually no, multiple acyl-CoA dehydrogenase deficiency cannot be fully prevented because it is an inherited condition that people are born with. If this condition runs in your family, genetic counseling and carrier testing before pregnancy may help you understand the chance of having a child with it. Newborn screening and early treatment can help prevent some serious problems, but they do not stop the condition itself from being there.
Transmission
Multiple acyl-CoA dehydrogenase deficiency is not infectious, so it cannot be passed from one person to another through coughing, kissing, sex, food, or everyday contact. Instead, the genetic transmission of Multiple acyl-CoA dehydrogenase deficiency usually happens when a child inherits two nonworking copies of a gene involved in how the body turns fat and protein into energy, one from each parent.
This means it is most often inherited in an autosomal recessive pattern: the parents are usually healthy carriers, and with each pregnancy there is a 25% chance the child will have Multiple acyl-CoA dehydrogenase deficiency, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither changed copy. In other words, Multiple acyl-CoA dehydrogenase deficiency is very rare, but it is not contagious at all.
When to test your genes
Consider genetic testing if newborn screening is abnormal, there is a family history of multiple acyl-CoA dehydrogenase deficiency, or someone has unexplained low blood sugar, muscle weakness, liver problems, or metabolic crises. Testing can confirm the diagnosis, guide treatment such as riboflavin use in some forms, and support family planning.
Diagnosis
Multiple acyl-CoA dehydrogenase deficiency is usually diagnosed when a person has a pattern of symptoms and test results that suggest the body is not breaking down certain fats and proteins properly. In babies, this may show up as low energy, poor feeding, low blood sugar, or trouble breathing, while in older children or adults it can look more like muscle weakness, vomiting, or episodes brought on by illness or fasting. Getting a diagnosis is often a turning point toward answers and support. The diagnosis of multiple acyl-CoA dehydrogenase deficiency is then confirmed with specialized lab and genetic tests.
Doctors first look at the overall pattern of symptoms, age at onset, and whether problems worsen during fasting, illness, or heavy exercise. They also check for signs such as low muscle tone, liver problems, or delayed growth, which can point toward this condition.
Blood tests can show low blood sugar, changes in body acids, high ammonia, or signs of muscle breakdown during a metabolic crisis. These results do not prove the condition on their own, but they help raise suspicion and guide urgent care.
A special blood test measures acylcarnitines, which are small compounds that build up when energy pathways are blocked. In multiple acyl-CoA dehydrogenase deficiency, this pattern is often broad and distinctive, making it one of the key clues.
Urine testing looks for abnormal organic acids and related substances that the body produces when it cannot process fats and some amino acids normally. The pattern may be especially noticeable during illness or after not eating for a while.
How is Multiple acyl-coa dehydrogenase deficiency diagnosed?
Multiple acyl-CoA dehydrogenase deficiency is usually diagnosed by putting together a person’s symptoms, the exam, and special blood and urine tests that show the body is not breaking down fats and some proteins the way it should. In babies, it may first be picked up on newborn screening, and doctors may also check blood sugar and other signs of stress on the liver, muscles, or heart. A genetic test can help confirm the diagnosis, and in some cases doctors also use other lab tests to measure how well the body’s energy-making system is working.
Stages of Multiple acyl-coa dehydrogenase deficiency
Multiple acyl-coa dehydrogenase deficiency does not have defined progression stages. This is because it is usually described by how severe it is, when it starts, and whether symptoms come in episodes, rather than by a steady step-by-step decline over time. Many people feel reassured knowing what their tests can—and can’t—show. Doctors usually diagnose and monitor multiple acyl-coa dehydrogenase deficiency using symptoms, blood and urine tests, and sometimes genetic testing, especially when early symptoms of multiple acyl-coa dehydrogenase deficiency suggest the body is having trouble turning food into energy.
Outlook and prognosis
The outlook for people with multiple acyl-CoA dehydrogenase deficiency varies widely and depends on the age at onset, severity, and whether the condition responds to treatment such as riboflavin and careful metabolic management. The most severe neonatal forms often have a poor prognosis, with high mortality in the newborn period or early infancy, especially when major heart, liver, or congenital abnormalities are present. In contrast, riboflavin-responsive and later-onset forms can have a much better outlook, and some people do well long term with prompt diagnosis, avoidance of fasting, and treatment during illness. Even in milder cases, episodes of metabolic decompensation, muscle weakness, low blood sugar, liver dysfunction, or rhabdomyolysis can still occur and may become life-threatening if not treated quickly. Early recognition, regular follow-up with a metabolic specialist, and emergency sick-day planning significantly improve outcomes.
Long-term effects
For many people, the long-term picture with multiple acyl-coa dehydrogenase deficiency depends a lot on when it starts and how severe it is. Some may have serious problems in infancy, while others live with a milder form that causes episodes of weakness, low energy, and trouble during illness or fasting. Long-term effects vary widely, and the outlook can range from life-threatening early disease to a more stable course with ongoing muscle and metabolic issues.
Many living with multiple acyl-coa dehydrogenase deficiency have ongoing muscle weakness that can limit walking, climbing stairs, lifting, or exercise. In milder forms, this may come and go, but over years some people are left with lasting fatigue or reduced stamina.
Repeated episodes of low blood sugar can remain a long-term risk, especially during fasting, vomiting, or other illness. In severe cases, these episodes can lead to seizures, confusion, or brain injury if they are prolonged.
Some people with multiple acyl-coa dehydrogenase deficiency develop an enlarged liver or signs of liver stress over time. In babies with severe disease, liver failure can be part of the long-term burden and can affect survival.
The heart can be affected, sometimes causing cardiomyopathy, which means the heart muscle becomes weak or enlarged. When this happens, people may have poor feeding, shortness of breath, or reduced exercise tolerance, and severe cases can be dangerous.
How is it to live with Multiple acyl-coa dehydrogenase deficiency?
Living with multiple acyl-CoA dehydrogenase deficiency often means paying close attention to your body’s energy limits, because long gaps without food, illness, heavy exercise, or other physical stress can trigger weakness, vomiting, low blood sugar, or muscle pain. For many people living with this condition, daily life may involve regular meals, special diet plans, supplements or medicines, and a clear emergency plan for sick days, although the day-to-day impact can vary a lot depending on how severe the condition is. It also affects the people around you, since family members, caregivers, teachers, or partners may need to help watch for early warning signs, support food and medication routines, and act quickly if an emergency develops.
Treatment and drugs
Multiple acyl-CoA dehydrogenase deficiency is usually treated by supporting the body’s energy use and preventing metabolic crises, especially during illness, fasting, or other stress. Treatment often looks different for each person, but it may include avoiding long gaps without food, using a special eating plan, and taking supplements such as riboflavin, carnitine, or CoQ10 when a specialist recommends them. Some people, especially those with riboflavin-responsive forms of multiple acyl-CoA dehydrogenase deficiency, improve clearly with vitamin treatment, while others need closer day-to-day management. During infections or other times when the body is under strain, quick treatment with extra fluids, sugar, and hospital care may be needed to protect the heart, muscles, liver, and brain. Because early treatment for multiple acyl-CoA dehydrogenase deficiency can make a real difference, care is usually guided by a metabolic specialist who adjusts the plan over time.
Can you cure Multiple acyl-coa dehydrogenase deficiency?
No, there is currently no cure for multiple acyl-CoA dehydrogenase deficiency, a rare inherited condition that makes it hard for the body to turn certain fats and proteins into energy. Treatment cannot take the condition away, but it can help control symptoms and lower the risk of serious problems with a carefully planned diet, avoiding long periods without food, supplements such as riboflavin (vitamin B2) for some people, and fast treatment during illness.
Non-drug treatment
Day to day, many people living with Multiple acyl-coa dehydrogenase deficiency need steady food intake and careful energy planning to help prevent muscle weakness, low blood sugar, and metabolic crises. Treatment is usually guided by a metabolic specialist and tailored to age, symptoms, and how severe the condition is. Managing this condition often means building routines that lower stress on the body, especially during illness, heavy exercise, or long gaps without eating. Non-drug care works best when it is started early and adjusted over time.
Regular meals and snacks help give the body a steady fuel supply and reduce the risk of fasting-related breakdown. For infants and some children, this may include overnight feeds or other planned nutrition support. The right schedule depends on age, growth, and how often symptoms flare.
Many people with Multiple acyl-coa dehydrogenase deficiency follow a tailored eating plan that limits stress on fat breakdown while still supporting growth and daily energy needs. The diet for Multiple acyl-coa dehydrogenase deficiency may also adjust protein and total calories based on lab results and symptoms. A metabolic dietitian usually helps fine-tune this safely.
Going too long without food can trigger weakness, vomiting, sleepiness, or a metabolic emergency. Families are often taught exact maximum fasting times for daytime and overnight. This can matter even more during growth spurts, travel, or missed meals.
Illness can quickly raise energy needs while making it harder to eat or drink enough. A written sick-day plan usually explains when to give extra carbohydrates, when to stop exercise, and when urgent medical care is needed. If one method does not help, there are usually other options to support nutrition, including hospital-based fluids if needed.
Your genes may have an impact on how drugs work for you
For people living with multiple acyl-CoA dehydrogenase deficiency, inherited changes in the body’s energy-making system can affect how well certain treatments work, especially riboflavin, a form of vitamin B2 that helps some people improve a lot while others improve less. Some may also be more sensitive to medicines that put extra strain on how the body uses fat for energy, so a treatment that seems routine for most people may need more caution here. Because of this, care is usually tailored to the individual, with the medical team watching closely for benefit and side effects rather than assuming everyone will respond the same way.
Pharmacological treatments
Treatment for multiple acyl-coa dehydrogenase deficiency usually centers on a few supportive medicines and vitamins that help the body use fat and protein for energy more safely. Riboflavin is the best-known treatment, especially in riboflavin-responsive forms, and other supplements may be added based on lab results and symptoms. Not everyone responds to the same medication in the same way. In babies or during illness, hospital treatment with glucose may also be needed, but that is usually an emergency measure rather than a daily medicine.
Riboflavin, a form of vitamin B2, is often the main treatment for multiple acyl-coa dehydrogenase deficiency. It can improve muscle weakness, low energy, and some early symptoms of multiple acyl-coa dehydrogenase deficiency, especially in people with riboflavin-responsive disease.
Levocarnitine may be used when carnitine levels are low, because this nutrient helps move fats into cells for energy use. Doctors use it selectively, since it is not right for everyone and is usually guided by blood test results.
Coenzyme Q10 may be added for some people with multiple acyl-coa dehydrogenase deficiency, particularly when muscle symptoms or low energy remain a problem. It is used as supportive treatment rather than a cure, and benefit can vary from person to person.
During metabolic crises, hospitals may give intravenous glucose to provide a safer energy source and reduce the body's need to break down fat. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy).
Genetic influences
For many living with multiple acyl-CoA dehydrogenase deficiency, going too long without food or getting sick can quickly strain the body’s energy supply, and this happens because of an inherited gene change. Most cases are caused by changes in the ETFA, ETFB, or ETFDH genes, which help cells break down fats and some proteins to make fuel. Multiple acyl-CoA dehydrogenase deficiency is usually inherited in an autosomal recessive pattern, meaning a child inherits one changed copy of the gene from each parent; parents are often healthy carriers and may not know they have passed it on. Even with the same gene change, people can develop early symptoms of multiple acyl-CoA dehydrogenase deficiency at very different ages and with very different severity. This helps explain why some babies become seriously ill soon after birth, while others are not diagnosed until later in childhood or adulthood. Because the genetic cause is well established, family history and genetic testing can help confirm the diagnosis and clarify risk for relatives.
Is Multiple acyl-coa dehydrogenase deficiency genetic?
Genetics are central to Multiple acyl-coa dehydrogenase deficiency, because it is caused by inherited changes in genes involved in energy metabolism. These genetic variations largely determine whether the condition develops and can also influence how severe it is.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal and common part of human biology across the general population. Most do not directly affect health and are simply part of the natural range of human diversity. In many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental factors also contribute. In some situations, though, a single well-understood variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for Multiple acyl-CoA dehydrogenase deficiency is often shaped by the exact gene change causing it, because some forms respond much better to certain therapies than others. For example, many people with changes in a gene called ETFDH improve with riboflavin, also known as vitamin B2, while severe early-onset forms linked to other genes may need more intensive nutrition support and closer monitoring. Genetic testing helps doctors decide how strongly to consider treatments such as riboflavin, carnitine, and a tailored eating plan that limits fasting and helps the body avoid energy crashes. Genetics is only one factor, though, and response can also vary with age, illness, and how early treatment begins. This is why genetic testing for Multiple acyl-CoA dehydrogenase deficiency can be useful not just for diagnosis, but also for choosing treatment and setting realistic expectations.
Interactions with other conditions
People living with multiple acyl-CoA dehydrogenase deficiency can become much more unwell during common illnesses, especially infections with fever, vomiting, or diarrhea. A simple stomach bug or chest infection may make it harder for the body to use fats and some proteins for energy, so symptoms such as low blood sugar, weakness, sleepiness, breathing problems, or worsening muscle pain can appear quickly. Doctors call it a comorbidity when two conditions occur together, and in this disorder other health problems such as liver disease, heart weakness, or ongoing muscle disease can add to day-to-day strain and raise the risk of metabolic crises. For many, this can mean that dehydration, fasting, or recovery after surgery becomes riskier than it would be for someone without multiple acyl-CoA dehydrogenase deficiency. In infants and children especially, the early symptoms of multiple acyl-CoA dehydrogenase deficiency may first show up when another illness places extra stress on the body. Because of this, families are often advised to treat infections promptly, avoid long gaps without food, and work with their medical team on a sick-day plan.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multiple acyl-coa dehydrogenase deficiency?
Other inherited energy problems can look a lot like multiple acyl-CoA dehydrogenase deficiency, especially other disorders in which the body cannot properly use fat for fuel, carnitine problems, and some mitochondrial diseases. Doctors may also consider conditions that affect how the body stores sugar or how muscles make energy, because these can also cause low blood sugar, weakness, vomiting, poor feeding, or symptoms that flare during fasting or illness. In babies and young children, severe infection or other liver problems can sometimes seem similar at first, so blood and urine tests are often needed to tell them apart.
History
People living with multiple acyl-CoA dehydrogenase deficiency may face very different challenges depending on when it starts. Some become seriously ill in the newborn period, while others are not diagnosed until later childhood or adulthood, when day-to-day problems such as muscle weakness, low energy, or repeated episodes of feeling unwell after fasting begin to stand out. This wide range is one reason the condition took time to recognize clearly in medicine.
Early doctors first identified severe forms in babies who had trouble feeding, low blood sugar, breathing problems, and a buildup of acids in the body. Later, milder forms of multiple acyl-CoA dehydrogenase deficiency were recognized in older children and adults, including people with exercise intolerance, muscle pain, or episodes triggered by illness. What once looked like several separate problems gradually came into focus as one condition with a broad spectrum.
In recent decades, awareness has grown as better lab testing made it easier to spot patterns in blood and urine that point to problems with how the body uses fats and certain proteins for energy. From there, researchers showed that multiple acyl-CoA dehydrogenase deficiency is linked to changes affecting the body’s energy-making pathways. Knowing this history helps explain why early symptoms of multiple acyl-CoA dehydrogenase deficiency can differ so much from one person to another, and why some people are diagnosed only after years of unexplained symptoms.
As understanding improved, treatment also became more targeted. Doctors learned that some people benefit from avoiding long periods without food, treating infections quickly, and using vitamin-based therapy in certain forms of the condition. Today, newborn screening in some regions can identify multiple acyl-CoA dehydrogenase deficiency earlier, giving families and care teams a better chance to prevent crises and support healthier growth and daily life.